Impact of telemedicine on pediatric neuro-oncology in a developing country: The Jordanian-Canadian experience

Pediatric Blood and Cancer

Volumn 48, Issue 1, 2007, Pages 39-43

  Qaddoumi, Ibrahim ^a   Mansour, Asem ^a   Musharbash, Awni ^a   Drake, James ^b   Swaidan, Maisa ^a   Tihan, Tarik ^c   Bouffet, Eric ^b  

^a KING HUSSEIN CANCER CENTER   (Jordan)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Brain tumors; Developing countries; Telemedicine; Twinning

Indexed keywords

ARTICLE; BRAIN TUMOR; CAMERA; CANADA; CHILDHOOD CANCER; COMPUTER; DEVELOPING COUNTRY; DIAGNOSTIC VALUE; EPIDERMOID CYST; GLIOMA; HUMAN; JORDAN; MEDULLOBLASTOMA; OLIGODENDROGLIOMA; PRIORITY JOURNAL; TELEMEDICINE; TELEPHONE; VIDEOCONFERENCING;

BRAIN NEOPLASMS; CANADA; CHILD; DEVELOPING COUNTRIES; EDUCATION, MEDICAL, CONTINUING; FEMALE; HUMANS; JORDAN; MALE; REMOTE CONSULTATION; VIDEOCONFERENCING;

EID: 33845346465     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21085     Document Type: Article

References (28)

1. Wagner HP, Antic V. The problem of pediatric malignancies in the developing world. Ann NY Acad Sci 1997;824:193-204.
2. Pui C-H, Ribeiro RC. International Colaboration on childhood leukemia. Int J Hematol 2003;78:383-389.
3. Barr RD, Ribeiro RC, Agarwal BR, et al. Pediatric oncology in countries with limited resources. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology, 4th edition. Philadelphia: Lippincott Williams and Wilkins: 2002. p 1541-1552.
4. Veerman AJP, Sutaryo, Sumadiono. Twinning: A rewarding scenario for development of oncology services in transitional countries. Pediatr Blood Cancer 2005;45:103-106.
5. Howard SC, Pedrosa M, Lins M, et al. Establishment of a pediatric oncology program and outcomes of childhood acute lymphoblastic leukemia in a resource - Poor area. JAMA 2004;291:2471-2475.
6. Metzger ML, Howard SC, Pena A, et al. Outcome of childhood acute lymphoblastic leukaemia in resource-poor countries. Lancet 2003;362:706-708.
7. Masera G, Baez F, Biondi A, et al. North- South twinning in pediatric haemato-oncology. The La Mascota programme, Nicaragua. Lancet 1998;352:1923-1926.
8. Ribeiro RC, Bonilla M. A leukaemia treatment programme in El Salvador. Lancet 2000;356:s7.
9. Antillon F, Baez FL, Barr R, et al. AMOR: A proposed cooperative effort to improve outcomes of childhood cancer in central America. Pediatr Blood Cancer 2005;45:107-110.
10. Shearer PD, Pui C-H. The walls of a spacious room. Med Pediatr Oncol 2001;36:312-313.
11. Schlag PM. On the way t new horizons: Telemedicine in oncology. The Oncologist 1997;2:iii-iv.
12. Olsen DR, Bruland ØS, Davis BJ. Telemedicine in radiotherapy treatment planning: Requirements and applications. Radiother Oncol 2000;54:255-259.
13. Weinstein RS, Descour MR, Achyut C, et al. Telepathology overview: From concept to implementation. Hum Pathol 2001;32:1283-1299.
14. Szymas J, Wolf G, Papierz W, et al. Online internet-based robotic telepathology in the diagnosis of neuro-oncology cases: A teleneuropathology feasibility study. Hum Pathol 2001;32:1304-1308.
15. Eich HT, Muller RP, Schneeweiss A, et al. Initiation of a teleradiotherapeutic network for patients in German lymphoma studies. Int J Radiation Biol Phys 2004;58:805-808.
16. Pal A, Mbarika VWA, Cobb-Payton F, et al. Telemedicine diffusion in a developing country: The case of India. IEEE Trans Infor Technol Biomed 2005;9:59-65.
17. Ganapathy K. Telemedicine and neurosciences in developing countries. Surg Neurol 2002;58:388-394.
18. Ribeiro RC, Pui CH. Saving the children- improving childhood cancer treatment in developing countries. N Eng J Med 2005;352:2158-2160.
19. Wessels G, Hesseling PB. Outcome of children treated for cancer in the republic of Namibia. Med Pediatr Oncol 1996;27:160-164.
20. Wanyoike PK. Posterior fossa tumours in children at Kenyatta National Hospital, Nairobi. East Afr Med J 2004;81:258-260.
21. Lee ST. International education: 20 years after implementation of a training program. Neurosurgery 2001;48:1348-1351.
22. Pollack IF, Boyett JM, Yates AJ. The influence of central review on outcomes associations in childhood malignant gliomas: Results from the CCG-945 experience. Neuro-oncol 2003;5:197-207.
23. Saran F. Recent advances in pediatric neurooncology. Curr Opin Neurol 2002;15:671-677.
24. Zeltzer PM, Boyett JM, Finlay JL. Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medullo-blastoma in children: Conclusions from the Children's Cancer Group 921 randomized phase III study. J Clin Oncol 1999;17:832-845.
25. Merchant TE, Mulhern RK, Krasin MJ. Preliminary results from phase II trial of conformal radiation therapy and evaluation of radiation-related CNS effects for pediatric patients with localized ependymoma. J Clin Oncol 2004, 22:3156-3162.
26. Bouffet E, Perilongo G, Canete A, et al. Intracranial ependymomas in children: A critical review of prognostic factors and a plea for cooperation. Med Pediatr Oncol 1998;30:319-329.
27. Mulhern PK, Kepner JL, Thomas PR. Neuropsychologic functioning of survivors of childhood medulloblastomas randomized to receive conventional or reduced-dose craniospinal irradiation: a Pediatric Oncology Group Study. J Clin Oncol 1998;16:1723-1728.
28. Perilongo G. Considerations on the role of chemotherapy and modern radiotherapy in the treatment of childhood low grade gliomas. J Neurooncol 2005;75:301-307.